Apo-Oxycodone CR 20.0 mg

APO-OXYCODONE CR 20.0 MG is an extended-release tablet designed for oral use. It contains oxycodone hydrochloride, a potent opioid analgesic used for managing moderate to severe pain. This medication is manufactured by Apotex Inc. in Canada.

APO-OXYCODONE CR 20.0 MG is primarily used for the management of moderate to severe pain that requires around-the-clock, long-term treatment. The extended-release formulation is designed to provide sustained pain relief over an extended period. Oxycodone hydrochloride, the active ingredient, is an opioid analgesic that works by binding to opioid receptors in the brain and spinal cord, altering the perception of pain.

Common effects of APO-OXYCODONE CR 20.0 MG may include drowsiness, dizziness, nausea, and constipation. Some users may also experience itching, dry mouth, or vomiting. These effects can vary in intensity and duration depending on individual factors. Always consult a healthcare provider for personalized advice.

APO-OXYCODONE CR 20.0 MG should be handled with care and stored securely to prevent misuse. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication can cause respiratory depression, especially when taken in higher doses or combined with other central nervous system depressants.

APO-OXYCODONE CR 20.0 MG may interact with other medications, including alcohol, sedatives, and certain antidepressants. Combining this medication with other opioids or central nervous system depressants can increase the risk of severe side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.